X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs DISHMAN PHARMA - Comparison Results

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB DISHMAN PHARMA UNICHEM LAB/
DISHMAN PHARMA
 
P/E (TTM) x -29.9 25.1 - View Chart
P/BV x 0.6 3.3 19.4% View Chart
Dividend Yield % 2.6 0.7 393.1%  

Financials

 UNICHEM LAB   DISHMAN PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
DISHMAN PHARMA
Mar-16
UNICHEM LAB/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs382374 102.0%   
Low Rs234129 181.6%   
Sales per share (Unadj.) Rs116.3197.8 58.8%  
Earnings per share (Unadj.) Rs-18.921.2 -89.2%  
Cash flow per share (Unadj.) Rs-11.734.7 -33.8%  
Dividends per share (Unadj.) Rs5.002.00 250.0%  
Dividend yield (eoy) %1.60.8 204.2%  
Book value per share (Unadj.) Rs381.0179.9 211.8%  
Shares outstanding (eoy) m70.3480.69 87.2%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.61.3 208.2%   
Avg P/E ratio x-16.311.9 -137.2%  
P/CF ratio (eoy) x-26.27.2 -362.0%  
Price / Book Value ratio x0.81.4 57.8%  
Dividend payout %-26.49.4 -280.2%   
Avg Mkt Cap Rs m21,66820,306 106.7%   
No. of employees `0002.30.8 275.0%   
Total wages/salary Rs m2,0065,355 37.5%   
Avg. sales/employee Rs Th3,587.819,252.7 18.6%   
Avg. wages/employee Rs Th880.06,459.5 13.6%   
Avg. net profit/employee Rs Th-583.72,064.1 -28.3%   
INCOME DATA
Net Sales Rs m8,18015,961 51.3%  
Other income Rs m610265 229.9%   
Total revenues Rs m8,79016,226 54.2%   
Gross profit Rs m-1,3204,103 -32.2%  
Depreciation Rs m5051,091 46.3%   
Interest Rs m80944 8.5%   
Profit before tax Rs m-1,2952,334 -55.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m-21 -200.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m33624 5.4%   
Profit after tax Rs m-1,3311,711 -77.8%  
Gross profit margin %-16.125.7 -62.8%  
Effective tax rate %-2.626.7 -9.7%   
Net profit margin %-16.310.7 -151.8%  
BALANCE SHEET DATA
Current assets Rs m23,31811,018 211.6%   
Current liabilities Rs m4,6359,517 48.7%   
Net working cap to sales %228.49.4 2,428.7%  
Current ratio x5.01.2 434.5%  
Inventory Days Days122110 110.2%  
Debtors Days Days12135 348.7%  
Net fixed assets Rs m8,16316,304 50.1%   
Share capital Rs m141161 87.2%   
"Free" reserves Rs m26,66012,907 206.6%   
Net worth Rs m26,80114,516 184.6%   
Long term debt Rs m34,189 0.1%   
Total assets Rs m31,89029,805 107.0%  
Interest coverage x-15.23.5 -437.1%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.30.5 47.9%   
Return on assets %-3.98.9 -44.0%  
Return on equity %-5.011.8 -42.1%  
Return on capital %-4.517.5 -25.9%  
Exports to sales %024.8 0.0%   
Imports to sales %03.7 0.0%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs mNA596 0.0%   
Fx inflow Rs m4,3564,952 88.0%   
Fx outflow Rs m0697 0.0%   
Net fx Rs m4,3564,255 102.4%   
CASH FLOW
From Operations Rs m-1,1232,786 -40.3%  
From Investments Rs m16,487-1,529 -1,078.3%  
From Financial Activity Rs m-8,811-941 936.3%  
Net Cashflow Rs m6,552316 2,070.8%  

Share Holding

Indian Promoters % 50.1 61.4 81.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 3.7 408.1%  
FIIs % 3.0 12.7 23.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 22.1 143.4%  
Shareholders   20,176 46,261 43.6%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   SUVEN LIFE  SHASUN PHARMA  PFIZER  FDC LTD.  SUN PHARMA  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

From Urjit Patel to Shaktikanta Das; What Lies Ahead?(Podcast)

The week gone by saw Sensex plunge from 700 points to rise by over 600 points. With a volatile and eventful week, it was a challenge keeping up with the news every day.

Related Views on News

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

It's Almost the Perfect Time to Buy This Safe Stock(The 5 Minute Wrapup)

Dec 6, 2018

My latest StockSelect recommendation ticks all the boxes of a great safe stock.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

Are Foreign Investors Heading Back to the Indian Stock Markets?(Chart Of The Day)

Dec 3, 2018

After months of heavy FII selling, November witnessed a return on foreign money into Indian equities...

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Dec 14, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - LUPIN LTD COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS